CTRI/2023/01/048953
Not yet recruiting
未知
Development of prediction model for potential drug-drug interactions between anti-tuberculosis drugs and co-medications among tuberculosis patients.
DR TMA PAI PhD FELLOWSHIP0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- DR TMA PAI PhD FELLOWSHIP
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Tuberculosis patients who take anti\-tuberculosis drugs and comedications
- •Tuberculosis patients aged 18 and above
Exclusion Criteria
- •Patients with liver abnormalities based on abnormal liver function tests during admission
- •Pregnant and lactating tuberculosis patients
- •Mentally challenged tuberculosis patients
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Development of Prediction Model for Response to Biologics and Small Molecular Agent for UCKCT0006979Asan Medical Center300
Not yet recruiting
Not Applicable
Drug monitoring method for Dasatinib in blood cancer patientsCTRI/2020/09/027561Tata Memorial Centre
Not yet recruiting
Not Applicable
Development of pharmacokinetic model for the target-concentration controlled infusion of cefazolin used as a prophylactic antibiotic in surgical patientsDiseases of the digestive systemKCT0005963Asan Medical Center40
Completed
Not Applicable
Development of pharmacokinetic model for the target-concentration controlled infusion of cefoxitin used as a prophylactic antibiotic in surgical patientsKCT0004442Asan Medical Center31
Not yet recruiting
Not Applicable
Development of prediction model for the efficacy of anti-PD-1 antibody on malignant pleural mesotheliomaJPRN-UMIN000034089Hyogo college of medicine50